The reported effectiveness of chlordiazepoxide in depressing the central nervous system led us to test this agent against cardiac arrhythmias induced by digitalis and coronary occlusion. The digitalis studies were performed in Dial-urethane anesthetized cats by monitoring: (1) ECG, (2) femoral arterial blood pressure, (3) right ventricular contractile force, and (4) spontaneous activity in cardiac sympathetic nerves. 
lidocaine is toxic to the central nervous system and its administration can result in muscular twitching and convulsions. -6 The need for new and better antiarrhythmic drugs is obvious, and in this regard there have been two general approaches to finding them. One approach is based on the idea that drugs must act directly on myocardial cell membranes to exert an antiarrhythmic effect.7 The other approach is based on the idea that drugs having neurodepressant effects can be used to suppress cardiac arrhythmias.Y2 These approaches derive from the assumptions that myocardial and neural components are both involved in the genesis of arrhythmias, and evidence exists to support each assumption.' 13' 14 Using the nervous system as a principal target in the search for new and effective antiarrhythmic drugs offers an important advantage. It should be far easier to find an agent that will selectively interfere with the neural component of an arrhythmia without damaging myocardial contractility than it would be to find an agent that would interfere with heart muscle electrical activity without interfering with muscle contractility. With this in mind we evaluated the antiarrhythmic activity of the neurodepressant substance-chlordiazepoxide-a drug reported to have negligible cardiovascular depressant effects at therapeutic blood levels. '5 Methods The effect of chlordiazepoxide on cardiac rhythm disturbances was investigated using arrhythmias induced by either digitalis or coronary occlusion. In the digitalis model, cats of either sex with weights ranging from 1.6 to 3.5 kg were anesthetized with 0.6 ml/kg i.p. of Dial-urethane. A tracheotomy was performed on all animals, and they were respired artificially with room air. The spinal cords and vagus nerves of eight of these animals were transected at the atlanto-occipital junction and at the cervical region, respectively. Catheters were inserted into the right femoral artery and vein of all animals for the purposes of measuring blood pressure and administering drugs, respectively. The animals' body temperatures were maintained between 37.0 and 38.5°C by an infrared lamp.
The heart and cardiac sympathetic nerves were exposed by excising the first three or four ribs on the right side. The pericardium was opened and a WaltonBrodie strain gauge arch was sutured to the right ventricle. The preganglionic sympathetic nerves to the right stellate ganglion were carefully dissected and placed on bipolar platinum recording electrodes. Assurance that the sympathetic nerve fibers were cardiac bound was obtained by stimulating them electrically and observing the effect on heart rate. Nerve activity was amplified, stored on magnetic tape and subsequently fed into a Grass integrator (Model 7P10B). Both the nerve activity and the integration of the activity with respect to time were displayed on a Grass polygraph (Model 7). The integrator was reset to zero at 10 sec intervals. Calibration of the integration system with reference to a known input was not done as we were only interested in relative changes in activity. Myocardial contractile force, femoral arterial blood pressure, and the electrocardiogram were recorded continuously on a Beckman RB recorder.
Two types of experiments were performed to evaluate the effects of chlordiazepoxide: 1) Deslanoside, 25 ,ug/kg i.v. every 15 min, to produce a stable ventricular arrhythmia of 1 min duration, followed by chlordiazepoxide in 10-15 mg i.v. increments given at approximately 45 sec intervals to revert deslanosideinduced ventricular arrhythmia to sinus rhythm (n = 12). The criteria for ventricular arrhythmia was a sustained idioventricular rhythm lasting at least one minute and characterized by the presence of independent nonconducted atrial activity.
2.) Deslanoside and chlordiazepoxide as in type 1, but administered to cats with spinal cord transections at C-1 and bilateral cervical vagotomy (n -8).
In the coronary occlusion model, dogs unselected as to age or sex and ranging from 18.5 to 23.5 kg in weight were anesthetized by an intravenous injection of pentobarbital sodium (30 mg/kg). Mechanical ventilation with room air was instituted with a cuffed endotracheal tube. Under sterile conditions the heart Circulation, Volume XLIX, February 1974 was exposed through the fourth left intercostal space and the pericardium incised. The anterior descending branch of the left coronary artery was dissected for a short length at a level about 1 cm distal to the left atrial appendage and occluded in two stages according to the method described by Harris.16 The chest was closed and a polyethylene catheter for injecting drugs was inserted into the jugular vein and exteriorized at the nape of the neck.
Animals were studied the following day, 26-31 hr after occlusion, in the unanesthetized state. All animals had been trained previously (i.e., before surgery) to lie quietly while ECG recordings (lead II) were made. In some animals, the electroencephalogram was recorded from standard EEG needle electrodes placed biparietally so that the needle tip entered obliquely and rested on the parietal bone. The low and high filters were set at 0.3 and 30 Hz, respectively. The ECG and EEG were displayed continuously on two channels of the polygraph. Preoperative electrocardiograms demonstrated sinus rhythm in all animals with heart rates ranging from 75 to 125 beats/min (mean value was 98 with a SE of + 9.4). The ECG revealed ventricular ectopic beats of multifocal origin. This arrhythmia was quantitated by counting every beat during a five minute period and noting the number which were of abnormal and normal origin.17 Control ECGs were taken for a 30 min period before the first dose of drug was administered. Chlordiazepoxide was used by dissolving the powder in 0.85% normal saline to a final concentration of 10 mg/cc. In the experiments where only the effect of chlordiazepoxide was studied, it was administered in a dose of 10 mg/kg by giving two injections of 5 mg/kg separated by a 5 min interval.
The drug was rapidly administered (i.e., over 3 sec) through the jugular vein catheter and the catheter was flushed rapidly with 5 cc of saline.
In the experiments where the effects of chlordiazepoxide on the antiarrhythmic and neurotoxic effects of lidocaine were studied, chlordiazepoxide was administered in a dose of 10 mg/kg (as described above) and was followed in 30 min by an additional 2.5 mg/kg. To obtain additional data on the role of the nervous system in the antiarrhythmic action of chlordiazepoxide, identical experiments were repeated in animals with transected spinal cords and sectioned vagus nerves. The animals required significantly greater doses of deslanoside to produce ventricular arrhythmias than did the animals with intact nervous systems (288 ± 15.7 jg/kg vs 165 + 9.5 jig/kg). Chlordiazepoxide was found to be ineffective for converting deslanoside-induced arrhythmias as sinus rhythm could not be reestablished in anv of the eight animals. An experiment illustrating the inability of chlordiazepoxide to colnvert the digitalis-induced ventricular arrhythmias to sinus rhythm in the neurally-deprived animals is shown in figure 3 .
The dose of chlordiazepoxide used for the conversion attempts in four animals was equivalent to the largest dose used in the animals with an intact nervous system. That is, a Idose up to 95 mg per cat was tested and failed to convert four of four animals. This represented 56 mg/kg in two animals and 35 and 43 mg/kg in the remaining two animals, respectively. A total dose of 95 mg per cat was attempted in the other four cats but was not achieved because each animal died from hypotension before the full amount could be administered. Doses which were lethal were 22, 26, 34, and 50 mg/kg and averaged 33 + 6.2 mg/kg. The average dose of chlordiazepoxide used in animals with an intact nervous system was 21 ± 3.7 mg/kg, and none of these animals was adversely affected, even though two animals received amounts greater than 33 mg/kg. Cardiac sympathetic nerve activity was monitored in four of the eight animals studied and a representative record of one of these appears as figure 4 . As can be seen, neither drug had an effect on nerve activity.
The contractile force, mean blood pressure, and heart rate data from the eight animals with ventricular arrhythmias and given chlordiazepoxide were averaged together and appear in table 2. The data from the four animals that died was extracted from the responses that occurred after the next to the last dose (i.e., fatal dose) was given and averaged together with data from the four survi- 30 minutes (see Methods), followed by 4 mg/kg lidocaine administered 2 min after the last dose of chlordiazepoxide. As reported previously,'8 4 mg/kg lidocaine alone has no significant antiarrhythmic effect but when administered after chlordiazepoxide in the present experiments it produced a significant reduction in the number of abnormal beats, a significant increase in sinus beats, and a significant degree of cardiac slowing. In fact the changes seen with the combination were all significantly greater than those changes seen with 4 mg/kg lidocaine alone (P < 0.05 using grouped Student's t-tests), as reported earlier. 18 The onset of action with the combination occurred 36 + 13.7 seconds after the beginning of the lidocaine injection. The peak effect was reached 2.0 0.45 minutes after the beginning of injection. The duration of action varied from 9 min to 30 min with a mean duration of 20.6 3.8 min. An experiment demonstrating the effect of the combination on the ECG appears as figure 6 .
Three additional experiments were performed wherein these same doses of chlordiazepoxide were given before the large 8 The doses of chlordiazepoxide required for exerting an antiarrhythmic effect were similar in all three studies. These doses exceed the average dose range (i.e., 50-100 mg i.v.) used in patients when administered for the purpose of reducing severe anxiety and tension. However, it must be kept in mind that much larger doses of antiarrhythmic drugs are generally required when one treats experimental arrhythmias in animals as compared to naturally occurring arrhythmias in patients. For The site of the chlordiazepoxide neurodepressant action seems to be the central nervous system. Our recordings of sympathetic nerve activity were from preganglionic cardiac autonomic fibers and the degree of activity present on these fibers probably reflects the degree of central nervous system activity. Depression of this activity by chlordiazepoxide may therefore represent a depression of central sympathetic tone. Consistent with this idea are the results of Schallek and Zabransky.32 They found that chlordiazepoxide in an i.v. dose of 40 mg/kg reduced the pressor response of hypothalamic stimulation in the cat. This dose had no significant effects in either the pressor responses to norepinephrine or to stimulation of the stellate ganglia, indicating that the drug does not block sympathetic responses at a peripheral site. Within the central nervous system, the most sensitive area in response to the benzodiazepines (i.e., diazepam) seems to be the hypothalamus. According to Chai and Wang,33 diazepam administered i.v. reduces the pressor responses evoked by electrical stimulation of the hypothalamus to a greater extent than the pressor responses evoked by the electrical stimulation of the medulla. Thus our data and the results of others strongly implicate the central nervous system, and more specifically the hypothalamus, as the principal site of action of chlordiazepoxide.
A central neural site of action for chlordiazepoxide is also consistent with the known mechanisms involved in the production of arrhythmias by either digitalis or coronary occlusion. For example, the arrhythmias produced by digitalis seem to result system structures9' 14 That is, digitalis enhances spontaneous neural activity in sympathetic, vagus, and phrenic nerves; the enhancement is associated with ventricular rhythm disturbances and respiratory hyperactivity. Removing the nervous system by spinal transection and vagotomy prevents these digitalis-induced neural effects and significantly increases the dose of digitalis necessary to produce ventricular rhythm disturbances. Likewise coronary occlusion produces a great increase in the discharge of sympathetic and parasympathetic nerves to the heart.13 The time course of the enhanced activity parallelsithe occurrence of ventricular arrhythmias. Furthermore, animals without abnormal neural input to the heart survive more than twice as long and have a significantly lower incidence of ventricular fibrillation. Based on mechanisms for the genesis of arrhythmias, an important consideration in therapy would be to quiet the nervous system.
As mentioned, no deleterious effects of chlordiazepoxide were observed in animals with intact nervous systems. We did however observe cardiovascular depressant effects of chlordiazepoxide in neurally-deprived animals. Significant decreases in contractile force and blood pressure occurred and half of the animals died as a consequence of these effects. The 
